BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35842836)

  • 1. Noncoding RNAs in diagnosis and prognosis of graft-versus-host disease (GVHD).
    Vajari MK; Moradinasab S; Yousefi AM; Bashash D
    J Cell Physiol; 2022 Sep; 237(9):3480-3495. PubMed ID: 35842836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of MicroRNA in Graft-Versus-Host-Disease: A Review.
    Pitea M; Canale FA; Porto G; Verduci C; Utano G; Policastro G; Alati C; Santoro L; Imbalzano L; Martino M
    Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
    Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
    Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
    Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Coding RNA Mediated Regulation of Allogeneic T Cell Responses After Hematopoietic Transplantation.
    Peltier D; Reddy P
    Front Immunol; 2018; 9():1110. PubMed ID: 29963039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of microRNAs for immunoregulation after allogeneic hematopoietic cell transplantation].
    Stickel N; Zeiser R
    Dtsch Med Wochenschr; 2014 Aug; 139(33):1673-8. PubMed ID: 25093955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
    Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of anti-CD4 antibody treatment and donor lymphocyte infusion ameliorates graft-versus-host disease while preserving graft-versus-tumor effects in murine allogeneic hematopoietic stem cell transplantation.
    Ueha S; Yokochi S; Ishiwata Y; Kosugi-Kanaya M; Shono Y; Shibayama S; Ito S; Matsushima K
    Cancer Sci; 2017 Oct; 108(10):1967-1973. PubMed ID: 28787768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.
    Ijaz A; Khan AY; Malik SU; Faridi W; Fraz MA; Usman M; Tariq MJ; Durer S; Durer C; Russ A; Parr NNC; Baig Z; Sagar F; Ali Z; McBride A; Anwer F
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):94-99. PubMed ID: 30195074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation.
    Tomuleasa C; Fuji S; Cucuianu A; Kapp M; Pileczki V; Petrushev B; Selicean S; Tanase A; Dima D; Berindan-Neagoe I; Irimie A; Einsele H
    Ann Hematol; 2015 Jul; 94(7):1081-92. PubMed ID: 25900787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Matsuda K; Ono S; Ishikawa M; Miyamoto S; Abiko S; Tsuda M; Yamamoto K; Kudo T; Shimizu Y; Hayase E; Hashimoto D; Teshima T; Matsuno Y; Sakamoto N
    Ann Hematol; 2018 May; 97(5):877-883. PubMed ID: 29340759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.
    Gao Y; Shan W; Gu T; Zhang J; Wu Y; Li X; Zeng X; Zhou H; Chen Z; Xiao H
    Front Immunol; 2021; 12():785774. PubMed ID: 34987512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The apheresis content analysis in Allo-HSCT represents reliable influential factors on graft-versus-host disease and overall survival.
    Rauofi A; Hajifathali A; Karami S; Tavakoli F; Roshandel E; Bonakchi H; Parkhideh S
    Transfus Apher Sci; 2021 Apr; 60(2):103009. PubMed ID: 33608218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
    Wetzel L; Wittig S; Gruhn B
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Bu X; Zhong J; Li W; Cai S; Gao Y; Ping B
    Ann Hematol; 2021 Jun; 100(6):1391-1400. PubMed ID: 33709198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral submucous fibrosis induced by graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Liu B; Cai J; Li W; Liu G; Chen J
    Oral Oncol; 2022 Jul; 130():105919. PubMed ID: 35594775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.